Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
British Journal of Cancer 114, 256 (02 February 2016). doi:10.1038/bjc.2015.467
Authors: S Diem, B Kasenda, L Spain, J Martin-Liberal, R Marconcini, M Gore & J Larkin
from Cancer via ola Kala on Inoreader http://ift.tt/23IAjES
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου